“…Protocols using supraphysiological doses of insulin in patients undergoing coronary artery bypass grafting showed anti-inflammatory and cardioprotective effects, as reflected by lower tumour necrosis factor a, interleukin 6, interleukin 8, and troponin levels. 92 These immunological changes were associated with a decreased requirement for inotropic support 93 and echocardiographic signs 94 of improved global myocardial function. 93 …”